Top
NME9 has not been detected as a mutational cancer driver

NME9
Ensembl id ENSG00000181322
Mutated samples
Coding Sequence 56 (0.8%)
Protein Affecting 28 (0.4%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all NME9 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 19 12 3.25
Bladder carcinoma No 3 3 3.06
Head and neck squamous cell carcinoma No 5 2 0.53
Lung adenocarcinoma No 1 1 0.26
Hepatocarcinoma No 2 1 1.11
Breast carcinoma No 4 1 0.09
Lung squamous cell carcinoma No 4 1 0.57
Pancreas adenocarcinoma No 1 1 0.47
Renal clear cell carcinoma No 2 1 0.24
Uterine corpus endometrioid carcinoma No 1 1 0.43
Serous ovarian adenocarcinoma No 1 1 0.32
Stomach adenocarcinoma No 3 1 0.62
Colorectal adenocarcinoma No 1 1 0.44
Esophageal carcinoma No 2 1 0.68
Acute myeloid leukemia No 1 0 0.00
Medulloblastoma No 1 0 0.00
Thyroid carcinoma No 1 0 0.00
Chronic lymphocytic leukemia No 2 0 0.00
Small cell lung carcinoma No 1 0 0.00
Glioblastoma multiforme No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence